[144] Clorox Company SEC Filing

Rhea-AI Filing Summary

Clorox Company (CLX) Form 144 notice reports a proposed sale of 15,041 shares of Common stock through UBS Financial Services on the NYSE with an aggregate market value of $1,861,847.74. The filing shows the shares were acquired and are proposed to be sold on 09/04/2025 following an employee stock option exercise paid in cash. The filer states there have been no securities sold by the account in the past three months and affirms no undisclosed material adverse information is known. The form is a routine Rule 144 notice documenting the intended compliant sale.

Positive

• Regulatory compliance: The filer disclosed the proposed sale under Rule 144, naming the broker and exchange and providing acquisition details
• Clarity of transaction: The filing specifies the acquisition method (employee stock option exercise), payment method (cash), and identical acquisition and proposed sale date

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 sale disclosed; 15,041 shares worth $1.86M were acquired by option exercise and are being offered through UBS.

The filing documents a standard Rule 144 notice for an insider or other restricted holder following an employee stock option exercise on the same date as the proposed sale. It provides key mechanics: broker (UBS), exchange (NYSE), number of shares (15,041), and aggregate market value ($1,861,847.74). No prior sales in the past three months are reported. The disclosure fulfills regulatory requirements and gives market participants visibility into a near-term potential sale of company stock.

Corporate Governance Expert

TL;DR: Compliance-focused filing showing adherence to Rule 144 sale-notice obligations after exercise of employee options.

The notice indicates the filer complied with procedural conditions by notifying the market via Form 144 and by representing no undisclosed material adverse information. The transaction is described as an employee stock option exercise with cash payment and immediate proposed sale through a named broker. The document contains no statements about trading plans or 10b5-1 arrangements and reports no other insider sales in the prior three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	15041	1861847.74	122309414	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/04/2025	Employee Stock Option Exercise	The Clorox Company			15041	09/04/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CLX report?

The form reports a proposed sale of 15,041 shares of Common stock via UBS on the NYSE with an aggregate market value of $1,861,847.74.

How were the 15,041 CLX shares acquired?

The shares were acquired on 09/04/2025 through an employee stock option exercise and payment was made in cash on the same date.

Does the filing report any sales in the prior three months?

No. The Form 144 indicates Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker and exchange are named in the notice?

The notice names UBS Financial Services Inc as the broker and the NYSE as the exchange for the proposed sale.

Does the filer indicate any undisclosed material information about Clorox?

By signing, the filer represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.